The use of cold-stored platelets to provide hemostasis in dogs with thrombocytopenia.
- 1Department of Veterinary Clinical Sciences, Washington State University College of Veterinary Medicine, Pullman, WA 99163 United States.
Abstract
Background
Platelet transfusion can be lifesaving in dogs with severe thrombocytopenia and hemorrhage, but platelet products are limited by short shelf life and contamination risk. Cold-stored platelets (CSP) may provide a practical alternative, but in vivo hemostatic efficacy in dogs is unknown.Hypothesis/objectives
Evaluate the clinical hemostatic efficacy and safety of CSP transfusions in thrombocytopenic dogs.Animals
Twenty-four thrombocytopenic dogs from a veterinary teaching hospital population that received CSP transfusions between March 2022 and October 2024.Methods
Retrospective cohort study. Medical records of dogs receiving platelet concentrate stored at 4 °C for up to 21 days were reviewed. Hemorrhage severity was assessed using a modified Daily Canine Bleeding Assessment Tool (DOGiBAT) score before transfusion and at 1 and 4 h post-transfusion. Primary outcomes included change in bleeding score, clinical response, transfusion reactions, and survival to discharge.Results
Twenty-four dogs received 27 CSP transfusions. Mean pre-transfusion platelet count was 23 × 103/μL (range, 2-107 × 103/μL) and mean post-transfusion count was 28 × 103/μL (range, 2-100 × 103/μL; P = .84). Mean DOGiBAT score decreased from 3.15 ± 2.4 at baseline to 2.21 ± 2.1 at 4 (mean change, -0.94; P = .002). Clinical improvement occurred in 19 of 27 transfusions (70%). No transfusion reactions were documented. Nineteen of 24 dogs (79%) survived to discharge.Conclusions and clinical importance
Cold-stored platelets were well-tolerated and associated with decreased bleeding severity in thrombocytopenic dogs, supporting CSP as a practical platelet transfusion option for clinical hemostatic support.
Related
- Enteroscopic hemostasis for bleeding hepatopetal collaterals around a hepaticojejunostomy.
- Dual-scope method for hemostasis during transbronchial lung cryobiopsy : A two-patient case report
- A Dual-Pump Switchable Irrigation System for Hemostasis under Gel Immersion during Water Pressure Duodenal Endoscopic Submucosal Dissection.
- Plant-derived modulators of the hemostasis-wound healing axis: mechanisms, evidence, and translational potential
- Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
BibTeX
@article{monaco2026coldstored,
title = {{The use of cold-stored platelets to provide hemostasis in dogs with thrombocytopenia.}},
author = {Shannon A Monaco and Jillian M Haines and Sarah C Guess and Sybil M Fiedler and K Jane Wardrop},
journal = {Journal of veterinary internal medicine},
year = {2026},
month = sep,
doi = {10.1093/jvimsj/aalag262},
url = {https://europepmc.org/article/MED/42912657},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - The use of cold-stored platelets to provide hemostasis in dogs with thrombocytopenia.
AU - Shannon A Monaco
AU - Jillian M Haines
AU - Sarah C Guess
AU - Sybil M Fiedler
AU - K Jane Wardrop
PY - 2026
DA - 2026/09/01
JO - Journal of veterinary internal medicine
DO - 10.1093/jvimsj/aalag262
UR - https://europepmc.org/article/MED/42912657
AB - Background Platelet transfusion can be lifesaving in dogs with severe thrombocytopenia and hemorrhage, but platelet products are limited by short shelf life and contamination risk. Cold-stored platelets (CSP) may provide a practical alternative, but in vivo hemostatic efficacy in dogs is unknown.Hypothesis/objectives Evaluate the clinical hemostatic efficacy and safety of CSP transfusions in thrombocytopenic dogs.Animals Twenty-four thrombocytopenic dogs from a veterinary teaching hospital population that received CSP transfusions between March 2022 and October 2024.Methods Retrospective cohort study. Medical records of dogs receiving platelet concentrate stored at 4 °C for up to 21 days were reviewed. Hemorrhage severity was assessed using a modified Daily Canine Bleeding Assessment Tool (DOGiBAT) score before transfusion and at 1 and 4 h post-transfusion. Primary outcomes included change in bleeding score, clinical response, transfusion reactions, and survival to discharge.Results Twenty-four dogs received 27 CSP transfusions. Mean pre-transfusion platelet count was 23 × 103/μL (range, 2-107 × 103/μL) and mean post-transfusion count was 28 × 103/μL (range, 2-100 × 103/μL; P = .84). Mean DOGiBAT score decreased from 3.15 ± 2.4 at baseline to 2.21 ± 2.1 at 4 (mean change, -0.94; P = .002). Clinical improvement occurred in 19 of 27 transfusions (70%). No transfusion reactions were documented. Nineteen of 24 dogs (79%) survived to discharge.Conclusions and clinical importance Cold-stored platelets were well-tolerated and associated with decreased bleeding severity in thrombocytopenic dogs, supporting CSP as a practical platelet transfusion option for clinical hemostatic support.
SN - 0891-6640
SN - 1939-1676
ER -